1. Home
  2. ATLO vs GBIO Comparison

ATLO vs GBIO Comparison

Compare ATLO & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ames National Corporation

ATLO

Ames National Corporation

HOLD

Current Price

$22.70

Market Cap

205.2M

Sector

Finance

ML Signal

HOLD

Logo Generation Bio Co.

GBIO

Generation Bio Co.

HOLD

Current Price

$5.45

Market Cap

36.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATLO
GBIO
Founded
1903
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
205.2M
36.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
ATLO
GBIO
Price
$22.70
$5.45
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$8.88
AVG Volume (30 Days)
28.9K
65.6K
Earning Date
01-23-2026
11-05-2025
Dividend Yield
3.48%
N/A
EPS Growth
82.57
N/A
EPS
1.80
N/A
Revenue
$60,568,000.00
$15,270,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$12.79
N/A
Revenue Growth
18.60
N/A
52 Week Low
$16.04
$3.00
52 Week High
$24.36
$12.40

Technical Indicators

Market Signals
Indicator
ATLO
GBIO
Relative Strength Index (RSI) 50.36 49.21
Support Level $22.62 $5.40
Resistance Level $23.18 $5.77
Average True Range (ATR) 0.45 0.22
MACD -0.15 0.02
Stochastic Oscillator 4.87 43.85

Price Performance

Historical Comparison
ATLO
GBIO

About ATLO Ames National Corporation

Ames National Corporation is a United States-based bank holding company. It provides short-term and medium-term commercial, multi-family, and agricultural real estate loans, residential real estate loans, agricultural and business operating loans and lines of credit, equipment loans, vehicle loans, personal loans and lines of credit, home improvement loans and origination of mortgage loans for sale into the secondary market. The Banks also offer a variety of checking, savings and time deposits, cash management services, merchant credit card processing, safe deposit boxes, wire transfers, direct deposit and automated/video teller machine access. The banking segment generates revenues through personal, business, agricultural and commercial lending, and Others.

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable differentiated therapeutic applications. Its first platform is a potent, selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

Share on Social Networks: